| Literature DB >> 27829425 |
Geoffrey Keith Mitchell1, Hugh Edgar Senior2,3, Michael Peter Bibo2, Blessing Makoni4, Sharleen Nicole Young2,5, John Patrick Rosenberg6, Patsy Yates6.
Abstract
BACKGROUND: Providing end of life care in rural areas is challenging. We evaluated in a pilot whether nurse practitioner (NP)-led care, including clinical care plans negotiated with involved health professionals including the general practitioner(GP), ± patient and/or carer, through a single multidisciplinary case conference (SMCC), could influence patient and health system outcomes.Entities:
Keywords: Case conferences; General practice; Nurse practitioner; Organisation of care; Palliative care; Primary care
Mesh:
Year: 2016 PMID: 27829425 PMCID: PMC5103592 DOI: 10.1186/s12904-016-0163-y
Source DB: PubMed Journal: BMC Palliat Care ISSN: 1472-684X Impact factor: 3.234
Fig. 1The Gold Standards framework for care plan development [5]
Fig. 2Study flow chart
Fig. 3Data collection and participant flow chart
Carer assessment scores at baseline
| Carer Support Needs Assessment tool |
| (Six carers, 14 potential need questions per carer; total needs considered = 84) |
| Potential needs with no extra help required = 60 (71%) |
| Potential needs with some extra help required = 22 (26%) |
| Potential needs with quite a bit more assistance required = 2 (2%)a |
| (One person each expressed the need for “quite a bit more assistance in “Knowing more about the patient’s illness”; and “Knowing what to expect in the future.”). |
| Family Satisfaction with advanced cancer care- FAMCARE-2. |
| Median total score 32.5, range 27–46 (Higher score, more satisfaction) |
| Median question score 1.9, range 1.8–7.4 |
| Overall quality of life |
| Mean 4.8, SD 0.8. (Range 0–7, Higher is better) |
| Overall satisfaction with the care of the patient (Single item. Range: very dissatisfied to very satisfied) |
| 5 responded satisfied or very satisfied. |
| HADS Depression Scale (Range 0–21)b |
| Median 6.5, range 1–9 |
| HADS Anxiety scale (Range 0–21)b |
| Median 8.0, range 2–15 |
aNot 100 % due to rounding. b Range 0–7. low depression/anxiety; 8–10- borderline; ≥ 11- clinically significant
Patient Demographics (n = 62)
| Female | 33 (53 %) |
| Age | |
| Mean (SD) (years) | 74.0 (12.3) |
| Median (Range) (years) | 75.6 (40–97) |
| Recorded primary disease | |
| Cancer | 21 (34 %) |
| Respiratory disease | 5 (8 %) |
| Heart/vascular | 4 (6 %) |
| Kidney disease | 4 (6 %) |
| Frailty | 3 (5 %) |
| Neurological disease | 3 (5 %) |
| Liver disease | 1 (2 %) |
| Dementia | 0 (0 %) |
| No primary cause recorded | 21 (43 %) |
Recorded symptoms discussed in case conferences (n (%))
| Pain (severe or moderate) | 13 (25 %) |
| Depression and/or anxiety | 12 (23 %) |
| Breathlessness | 10 (19 %) |
| Nausea/vomiting | 8 (15 %) |
| Constipation or diarrhoea | 4 (7 %) |
| Swallowing difficulties | 4 (7 %) |
| Urinary or bowel incontinence | 2 (2 %) |
| Falls risk | 2 (2 %) |
Referral by SCC to other agencies
| Allied Health (dietitian, social worker, physiotherapist, OT) | 5 |
| Mobility aids or supplemental oxygen | 4 |
| Referral to community nurse | 3 |
| Domestic help | 3 |
| Respite care | 2 |
| Arrange out-of-hours contacts | 17 |
Nurse practitioner initiated medication changes
| Medication type | New medications | Altered dose |
|---|---|---|
| Opioids | 10 | 3 |
| Paracetamol | 2 | - |
| Anti-emetics | 1 | 1 |
| Benzodiazepines | 2 | - |
| Anti-epileptic | 1 | 1 |
| Antidepressant | 1 | - |
| Diuretics | 1 | - |
| Steroids | 1 | - |
| Other | 5 | 4 |
| Total changes | 24 | 9 |